Fenbendazole 222mg capsules for humans are a very effective parasite treatment medication. Its sister drug mebendazole is also showing promise as an anti-cancer treatment in people, mainly due to the fact that it can stop cancer cells from processing sugar. It destroys microtubules and boosts the production of a gene called p53 that keeps cancer cells from proliferating. It is a very safe drug with a broad safety margin and has been used for years to treat tapeworm infections.
Both fenbendazole and mebendazole have been around for decades as parasite medicines but the buzz has been generated by lab experiments that show that they might kill some cancers. This type of discovery is a very exciting development because it might mean that this simple, cheap and easily available drug could be an inexpensive alternative to the high-cost, toxic and often unhelpful chemotherapy treatments that have been keeping cancer patients on life support while draining health insurance policies, gov’t subsidies and family fortunes.
In the lab experiments, fenbendazole (and mebendazole) inhibited growth of several tumors but did not affect normal tissue. When the drug was added to radiation, the effect was even more pronounced. The only drawback of this discovery is that fenbendazole is not yet available as an approved anticancer drug. Until it is, however, its low toxicity makes it an attractive experimental therapy for people with unresponsive cancers or those whose conventional therapies have failed. This would be an important first step towards a cure for cancer, which has been kept on life support by the pharmaceutical industry. fenbendazole 222mg capsules for humans